We are live on
!
Find out more
NICM
Neo Ivy Capital Management Portfolio holdings
AUM
$379M
1-Year Est. Return
28.34%
This Fund
S&P 500
This Quarter
Est. Return
-28.43%
1 Year Est. Return
+28.34%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$61.4M
AUM Growth
-$25.1M
(-29%)
Cap. Flow
-$72.2K
Cap. Flow
% of AUM
-0.12%
Top 10 Holdings %
Top 10 Hldgs %
8.67%
Holding
587
New
335
Increased
38
Reduced
76
Closed
138
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWO
Two Harbors Investment
TWO
|
+$1.02M |
| 2 |
Alaska Air
ALK
|
+$909K |
| 3 |
SLB Ltd
SLB
|
+$900K |
| 4 |
Trane Technologies
TT
|
+$768K |
| 5 |
American Financial Group
AFG
|
+$760K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$733K |
| 2 |
Dentsply Sirona
XRAY
|
+$704K |
| 3 |
Fidelity National Financial
FNF
|
+$703K |
| 4 |
United Parcel Service
UPS
|
+$703K |
| 5 |
IBM
IBM
|
+$702K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.11% |
| 2 | Industrials | 15.54% |
| 3 | Technology | 14.65% |
| 4 | Consumer Discretionary | 12.33% |
| 5 | Healthcare | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Azenta
AZTA
$1.49B
| $31K | 0.05% |
+1,002
| New | +$36.5K |
|
352
BioMarin Pharmaceuticals
BMRN
$13.3B
| $30K | 0.05% |
+356
| New | +$30.7K |
|
353
Incyte
INCY
$24.4B
| $30K | 0.05% |
404
-7,633
| -95% | -$577K |
|
|
ALXN
354
DELISTED
Alexion Pharmaceuticals
ALXN
| $30K | 0.05% |
+337
| New | +$33.1K |
|
355
Halozyme
HALO
$11.4B
| $29K | 0.05% |
+1,592
| New | +$30.2K |
|
356
Microchip Technology
MCHP
$42.2B
| $29K | 0.05% |
+864
| New | +$40.6K |
|
357
Ball Corp
BALL
$16.4B
| $27K | 0.04% |
+420
| New | +$29.4K |
|
358
Chegg
CHGG
$89.3M
| $27K | 0.04% |
749
-7,838
| -91% | -$306K |
|
359
Old Republic International
ORI
$10.3B
| $27K | 0.04% |
1,787
-10,981
| -86% | -$226K |
|
|
SEE
360
DELISTED
Sealed Air
SEE
| $27K | 0.04% |
+1,078
| New | +$35.2K |
|
|
BKI
361
DELISTED
Black Knight, Inc. Common Stock
BKI
| $27K | 0.04% |
+469
| New | +$30.7K |
|
362
Equity Lifestyle Properties
ELS
$12.6B
| $26K | 0.04% |
+453
| New | +$30.9K |
|
|
PCH
363
DELISTED
PotlatchDeltic
PCH
| $26K | 0.04% |
+833
| New | +$32.3K |
|
364
W.R. Berkley
WRB
$26.2B
| $25K | 0.04% |
1,076
-21,786
| -95% | -$649K |
|
365
A.O. Smith
AOS
$8.49B
| $24K | 0.04% |
+632
| New | +$26.9K |
|
366
Best Buy
BBY
$18B
| $24K | 0.04% |
+417
| New | +$33.1K |
|
|
K
367
DELISTED
Kellanova
K
| $24K | 0.04% |
+428
| New | +$26.2K |
|
368
AMN Healthcare
AMN
$1.34B
| $23K | 0.04% |
+391
| New | +$26.8K |
|
369
HF Sinclair
DINO
$16.3B
| $23K | 0.04% |
938
-4,869
| -84% | -$182K |
|
370
M&T Bank
MTB
$36.6B
| $23K | 0.04% |
+223
| New | +$32.8K |
|
371
Broadcom
AVGO
$1.99T
| $22K | 0.04% |
940
-18,740
| -95% | -$528K |
|
372
DexCom
DXCM
$34.5B
| $22K | 0.04% |
+332
| New | +$20.7K |
|
373
Lumentum
LITE
$78B
| $22K | 0.04% |
+301
| New | +$23.7K |
|
374
CVS Health
CVS
$121B
| $21K | 0.03% |
347
-9,097
| -96% | -$607K |
|
375
FMC
FMC
$1.27B
| $21K | 0.03% |
+260
| New | +$24.1K |
|
Similar funds
MC
ACA
AFCM
DAL
SFWC
MWM
STP
RC
Neo Ivy Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Neo Ivy Capital Management held 587 positions worth $61.4M, down 29% from $86.5M the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Neo Ivy Capital Management's Q1 2020 filing shows 335 new, 38 increased, 76 reduced and 138 closed positions. Its largest new stake was Two Harbors Investment: 20,048 shares worth $306K. The largest sale was Gilead Sciences, an estimated $733K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 14% a quarter earlier, followed by Industrials and Technology.
- Neo Ivy Capital Management's largest Q1 2020 buy was Two Harbors Investment: 20,048 shares worth $306K.
- Neo Ivy Capital Management added most to Trane Technologies in Q1 2020, an estimated $768K increase.
- Neo Ivy Capital Management's biggest Q1 2020 reduction was Gilead Sciences, cutting an estimated $733K.
- Neo Ivy Capital Management fully exited Dentsply Sirona in Q1 2020, selling an estimated $704K.
- Neo Ivy Capital Management's ten largest holdings make up 8.7% of its $61.4M portfolio in Q1 2020.
- Neo Ivy Capital Management opened 335 new positions and closed 138 in Q1 2020.
- Neo Ivy Capital Management's portfolio value fell 29% quarter-over-quarter to $61.4M.
Based on Neo Ivy Capital Management's 13F filing for Q1 2020, filed 15 May 2020.